View in EDS HTML Full Text PDF Full Text

The Impact of COVID-19 Vaccination on Symptoms of Anxiety and Depression before and after COVID-19 Vaccines Were Universally Available for Adults in the United States.

Saved in:
Bibliographic Details
Title: The Impact of COVID-19 Vaccination on Symptoms of Anxiety and Depression before and after COVID-19 Vaccines Were Universally Available for Adults in the United States.
Authors: Parcesepe, Angela M. (AUTHOR), Nash, Denis (AUTHOR), Shen, Jenny (AUTHOR), Kulkarni, Sarah G. (AUTHOR), Zimba, Rebecca (AUTHOR), You, William (AUTHOR), Berry, Amanda (AUTHOR), Piltch-Loeb, Rachael (AUTHOR), Fleary, Sasha A. (AUTHOR), Stanton, Eva (AUTHOR), Grov, Christian (AUTHOR), Robertson, McKaylee M. (AUTHOR)
Source: Depression & Anxiety (1091-4269). 5/7/2024, Vol. 2024, p1-12. 12p.
Subjects: COVID-19 vaccines, Mental depression, Vaccine hesitancy, Vaccination status, Adults, Anti-vaccination movement
Geographic Terms: United States
Abstract: Our objective was to examine the influence of COVID-19 vaccination on recent (i.e., past month) moderate or severe symptoms of anxiety (GAD ‐ 7 ≥ 10) or depression (PHQ ‐ 8 ≥ 10) before and after the COVID-19 vaccine became universally available for adults in the U.S. Participants belonged to the Communities, Households, and SARS-CoV-2 Epidemiology Cohort (CHASING COVID), a national longitudinal study. Our analytic population included 4,832 participants who reported vaccination status from December 2020 to December 2021 with follow-up outcomes assessed through March 2022. We emulated a hypothetical randomized experiment, a target trial, to estimate the effect of COVID-19 vaccination on symptoms of anxiety or depression. Before vaccines were universally available, participants who were vaccinated versus not had significantly lower adjusted odds of symptoms of moderate or severe anxiety (aOR: 0.79; 95% CI: 0.70-0.89). In the universal vaccine era, vaccination was associated with marginally higher adjusted odds of symptoms of moderate or severe anxiety (aOR: 1.23; 95% CI: 1.00-1.50). Vaccination did not influence subsequent moderate or severe depressive symptoms in the preuniversal vaccine era (aOR: 0.92; 95% CI: 0.82-1.03) or universal vaccine era (aOR: 1.11; 95% CI: 0.91-1.36). Research into the longitudinal relationship between COVID-19 vaccination and symptoms of depression and anxiety is warranted, with a focus on advancing understanding of potential mediators on the pathway between vaccination and mental health as well as modifiable factors, such as vaccine hesitancy or vaccine beliefs, that may help identify populations for whom vaccination may be particularly beneficial to their mental health. [ABSTRACT FROM AUTHOR]
Copyright of Depression & Anxiety (1091-4269) is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Psychology and Behavioral Sciences Collection
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: pbh
DbLabel: Psychology and Behavioral Sciences Collection
An: 177166656
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: The Impact of COVID-19 Vaccination on Symptoms of Anxiety and Depression before and after COVID-19 Vaccines Were Universally Available for Adults in the United States.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Parcesepe%2C+Angela+M%2E%22">Parcesepe, Angela M.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Nash%2C+Denis%22">Nash, Denis</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Shen%2C+Jenny%22">Shen, Jenny</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kulkarni%2C+Sarah+G%2E%22">Kulkarni, Sarah G.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zimba%2C+Rebecca%22">Zimba, Rebecca</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22You%2C+William%22">You, William</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Berry%2C+Amanda%22">Berry, Amanda</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Piltch-Loeb%2C+Rachael%22">Piltch-Loeb, Rachael</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Fleary%2C+Sasha+A%2E%22">Fleary, Sasha A.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Stanton%2C+Eva%22">Stanton, Eva</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Grov%2C+Christian%22">Grov, Christian</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Robertson%2C+McKaylee+M%2E%22">Robertson, McKaylee M.</searchLink> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Depression+%26+Anxiety+%281091-4269%29%22">Depression & Anxiety (1091-4269)</searchLink>. 5/7/2024, Vol. 2024, p1-12. 12p.
– Name: Subject
  Label: Subjects
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22COVID-19+vaccines%22">COVID-19 vaccines</searchLink><br /><searchLink fieldCode="DE" term="%22Mental+depression%22">Mental depression</searchLink><br /><searchLink fieldCode="DE" term="%22Vaccine+hesitancy%22">Vaccine hesitancy</searchLink><br /><searchLink fieldCode="DE" term="%22Vaccination+status%22">Vaccination status</searchLink><br /><searchLink fieldCode="DE" term="%22Adults%22">Adults</searchLink><br /><searchLink fieldCode="DE" term="%22Anti-vaccination+movement%22">Anti-vaccination movement</searchLink>
– Name: SubjectGeographic
  Label: Geographic Terms
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22United+States%22">United States</searchLink>
– Name: Abstract
  Label: Abstract
  Group: Ab
  Data: Our objective was to examine the influence of COVID-19 vaccination on recent (i.e., past month) moderate or severe symptoms of anxiety (GAD ‐ 7 ≥ 10) or depression (PHQ ‐ 8 ≥ 10) before and after the COVID-19 vaccine became universally available for adults in the U.S. Participants belonged to the Communities, Households, and SARS-CoV-2 Epidemiology Cohort (CHASING COVID), a national longitudinal study. Our analytic population included 4,832 participants who reported vaccination status from December 2020 to December 2021 with follow-up outcomes assessed through March 2022. We emulated a hypothetical randomized experiment, a target trial, to estimate the effect of COVID-19 vaccination on symptoms of anxiety or depression. Before vaccines were universally available, participants who were vaccinated versus not had significantly lower adjusted odds of symptoms of moderate or severe anxiety (aOR: 0.79; 95% CI: 0.70-0.89). In the universal vaccine era, vaccination was associated with marginally higher adjusted odds of symptoms of moderate or severe anxiety (aOR: 1.23; 95% CI: 1.00-1.50). Vaccination did not influence subsequent moderate or severe depressive symptoms in the preuniversal vaccine era (aOR: 0.92; 95% CI: 0.82-1.03) or universal vaccine era (aOR: 1.11; 95% CI: 0.91-1.36). Research into the longitudinal relationship between COVID-19 vaccination and symptoms of depression and anxiety is warranted, with a focus on advancing understanding of potential mediators on the pathway between vaccination and mental health as well as modifiable factors, such as vaccine hesitancy or vaccine beliefs, that may help identify populations for whom vaccination may be particularly beneficial to their mental health. [ABSTRACT FROM AUTHOR]
– Name: AbstractSuppliedCopyright
  Label:
  Group: Ab
  Data: <i>Copyright of Depression & Anxiety (1091-4269) is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.)
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=177166656
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1155/2024/9682710
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 12
        StartPage: 1
    Subjects:
      – SubjectFull: COVID-19 vaccines
        Type: general
      – SubjectFull: Mental depression
        Type: general
      – SubjectFull: Vaccine hesitancy
        Type: general
      – SubjectFull: Vaccination status
        Type: general
      – SubjectFull: Adults
        Type: general
      – SubjectFull: Anti-vaccination movement
        Type: general
      – SubjectFull: United States
        Type: general
    Titles:
      – TitleFull: The Impact of COVID-19 Vaccination on Symptoms of Anxiety and Depression before and after COVID-19 Vaccines Were Universally Available for Adults in the United States.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Parcesepe, Angela M.
      – PersonEntity:
          Name:
            NameFull: Nash, Denis
      – PersonEntity:
          Name:
            NameFull: Shen, Jenny
      – PersonEntity:
          Name:
            NameFull: Kulkarni, Sarah G.
      – PersonEntity:
          Name:
            NameFull: Zimba, Rebecca
      – PersonEntity:
          Name:
            NameFull: You, William
      – PersonEntity:
          Name:
            NameFull: Berry, Amanda
      – PersonEntity:
          Name:
            NameFull: Piltch-Loeb, Rachael
      – PersonEntity:
          Name:
            NameFull: Fleary, Sasha A.
      – PersonEntity:
          Name:
            NameFull: Stanton, Eva
      – PersonEntity:
          Name:
            NameFull: Grov, Christian
      – PersonEntity:
          Name:
            NameFull: Robertson, McKaylee M.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 07
              M: 05
              Text: 5/7/2024
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-print
              Value: 10914269
          Numbering:
            – Type: volume
              Value: 2024
          Titles:
            – TitleFull: Depression & Anxiety (1091-4269)
              Type: main
ResultId 1